<DOC>
	<DOCNO>NCT01762748</DOCNO>
	<brief_summary>The purpose study evaluate effect Saccharomyces boulardii patient wait list liver transplant .</brief_summary>
	<brief_title>Effect Saccharomyces Boulardii Patients Waiting List Liver Transplant</brief_title>
	<detailed_description>Increased intestinal permeability relate major complication liver cirrhosis . The administration probiotic suggest improve barrier function mucosa consequently avoid complication disease . The objective study evaluate effect Saccharomyces boulardii patient wait list liver transplant . Eighteen patient treat Saccharomyces boulardii . Intestinal permeability ( lactulose/mannitol ratio ) laboratory parameter evaluate immediately begin treatment , thirty-day period treatment probiotic end second study month ( thirty-day period without treatment probiotic ) . Twenty healthy volunteer also submit intestinal permeability test .</detailed_description>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>patient wait list liver transplant viral , alcoholic cryptogenic cirrhosis patient young 18 year old 65 year . patient renal failure , congestive heart failure , nephrotic syndrome , diabetes thyroid disease interfered absorption , flux water solutes intestinal motility , order avoid interference intestinal permeability test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Probiotic</keyword>
	<keyword>liver</keyword>
	<keyword>transplant</keyword>
	<keyword>permeability</keyword>
</DOC>